Earlier this summer, we told you about the Valeritas V-Go system that is undergoing a small initial launch on the East Coast. We wanted to follow-up and give you a closer look at this product, which isn’t what you might normally think of when you hear the term “insulin pump”; it represents a new breed of delivery device for the growing number of type 2 PWDs on insulin.
By D’Mine Columnist / Correspondent Wil Dubois…
We’ve been traveling the world for the past year, bringing you different perspectives on life with diabetes with our Global DiabetesSeries. This month, we’d like to introduce you to Mila Ferrer, who lives in San Juan, Puerto Rico, with her husband and three sons. Puerto Rico is closely tied to the U.S., as it is a commonwealth, but it is also distinctly different.
Currently working as Director of Operations for Fundación Dulces Guerreros, an organization for…
Read more »
We’re back with another edition of our Global Diabetes series, in which we’ve “traveled the world” to bring you the stories of people living with diabetes, from Germany and Spain to India and the United Arab Emirates. Today, Anja Nielsen joins us from Copenhagen, Denmark, where approximately 5% of the population has diabetes. Anja was diagnosed with type 1 diabetes in 1999, and soon after became an active diabetes advocate, involved in both the International…
Read more »
As we all know, there’s A LOT to remember when it comes to diabetes. So Timesulin, a virtual company founded in 2009 in Germany, Sweden and the UK, hopes to help patients remember whether or not they’ve taken their insulin injection.
Unlike insulin pumps, most insulin pens don’t come with a memory that you can scroll through to check whether or not you already bolused for your dinner. What to do if you’re unsure? Not taking…
If you’re an Apidra user, listen up!
Sanofi Aventis has announced that due to a technical malfunction at their plant in Frankfurt, Germany, production on all Apidra SoloSTAR insulin pens has come to a screeching halt. Sanofi has made it clear that this is an issue with the manufacturing of the pens themselves, not the insulin. Apidra insulin itself is running strong, and patients won’t have issues with previously manufactured insulin pens or any vials…